生物类似药的概述 - - 医疗保健中的发展,质量,监管问题和管理
Filipa Mascarenhas-Melo1,2, Mariana Diaz3, Maria Beatriz S Gonçalves3
1LAQV-REQUIMTE, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Pharmaceuticals (Basel, Switzerland)
|February 24, 2024
概括
生物仿制药为生物药品提供安全有效的替代品,增加患者获取和医疗保健的可持续性. 了解它们的发育和调控途径对于知情的临床使用至关重要.
科学领域:
- 生物制药的发展.
- 监管科学是一种监管科学.
- 临床药理学 临床药理学
背景情况:
- 生物疗法已经彻底改变了许多疾病的治疗方法.
- 生物药物的专利到期为生物类似药的开发铺平了道路.
- 生物类似药在安全性,质量和有效性方面与参考产品非常相似.
研究的目的:
- 审查生物仿制药的监管和制造要求.
- 为临床医生提供洞察力,以便明智地处方生物类似药.
- 解决围绕生物类似药物的现有争议和误解.
主要方法:
- 严格的逐步评估,包括分析,功能,非临床和临床研究.
- 临床试验的重点是证明类似的疗效,安全性和免疫性.
- 监管途径和制造标准的评估.
主要成果:
- 生物类似药不是完全相同的副本,并且与仿制药不同.
- 开发涉及广泛的比较研究,以确保与参考产品的相似性.
- 关于生物类似药的现有知识正在增长,但误解仍然存在.
结论:
- 生物类似发展促进竞争,可持续性和患者获取.
- 监管机构和开发人员之间的合作对于及时的患者利益至关重要.
- 开放的沟通和知情决策对于最大限度地利用生物类似药的好处至关重要.
相关概念视频
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Health Information Technology and Healthcare Information System
840
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
840
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


